MyFinsight
Home
Blog
About
Contact
bglc: the balance sheet
Download
Download image
Investments in equity
securities
$237,760
Property, plant and
equipment, net
$1,570,584
Operating lease
right-of-use assets
$186,082
Inventories (including
goods in transit of...
$1,007,448
Tax recoverable
$103,640
Other receivables,
deposits and prepayments
$98,903
Trade receivables,
net of allowance for...
$1,522,158
Fixed deposits placed
with financial...
$1,741,532
Cash and bank
balances
$1,153,121
Total non-current
assets
$1,994,426
Total current assets
$5,626,802
Total assets
$7,621,228
Total liabilities and
stockholders' equity
$7,621,228
Total stockholders'
equity
$6,816,262
Total liabilities
$804,966
Accumulated other
comprehensive losses
-$112,547
Accumulated deficit
-$5,391,110
Additional paid in capital
-$5,011,891
As at september 30,
2025, common stock, no...
$17,331,810
Total non-current
liabilities
$126,943
Total current
liabilities
$678,023
Non-current portion of
operating lease...
$126,943
Amount owing to
directors
$49,976
Advance payment from
customer
$11,264
Current portion of
operating lease...
$56,803
Other payables and
accrued liabilities
$375,380
Trade payables
$184,600
Back
Back
Balance Sheet
source: myfinsight.com
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp (BGLC)